top of page

SENSOR SYSTEMS
ENGINEERING
EMS
SERVICES+RESOURCES
- Events + Conventions
- NEWS
More

Use tab to navigate through the menu items.

DOWNLOAD AREA

PARTNER AREA

Medica 2024: PREMOSYS presents C.E.B.R.A. - Innovation from Rhineland-Palatinate

Medica 2024: PREMOSYS presents C.E.B.R.A. - Innovation from Rhineland-Palatinate

Medica 2024: PREMOSYS presents C.E.B.R.A. - Innovation from Rhineland-Palatinate

We're delighted to be live at MEDICA in Düsseldorf! As one of the innovative companies from Rhineland-Palatinate, we will be showcasing...

Nov 13, 2024

Where Precision Meets Innovation: PREMOSYS at MEDICA 2024 – Visit Us in Hall 3, Booth E92!

Where Precision Meets Innovation: PREMOSYS at MEDICA 2024 – Visit Us in Hall 3, Booth E92!

Where Precision Meets Innovation: PREMOSYS at MEDICA 2024 – Visit Us in Hall 3, Booth E92!

PREMOSYS GmbH is excited to announce our participation in MEDICA 2024, the world’s leading trade fair for the medical industry! From...

Nov 5, 2024

Dual spectrometry in your production line: increase efficiency and quality with PREMOSYS

Dual spectrometry in your production line: increase efficiency and quality with PREMOSYS

Dual spectrometry in your production line: increase efficiency and quality with PREMOSYS

Efficiency and quality are decisive factors in industrial manufacturing. With the world's first dual spectrometer eFLAT-S, PREMOSYS...

Oct 22, 2024

premosys.de

Products

Legal + Information

Data protection

Goods acceptance and shipping times

Data download

GmbH

Hillstrasse 14

54570 Kalenborn-Scheuern

Germany

+49 6591 98 311 0

Managing Director/CEO: Matthias Kuhl

Wittlich District Court HRB 12477

© 2025 PREMOSYS, Incorporated. All rights reserved.

The structural expansion of PREMOSYS into a technology campus was funded by the European Union from the European Regional Development Fund and the state of Rhineland-Palatinate.

EUROPEAN UNION

European Fund for

Regional Development

CO-FINANCED

VOM LAND

RHINELAND-PALATINATE

FUNDING PROJECT:

The aim of the INNOVASTAIN J+ feasibility study is to create the conditions for a new, innovative sensor system that can simultaneously capture both high-resolution color information and spectral data. A sensor chip is to be investigated and adapted for applications in medical technology in order to enable precise analyses of body fluids, tissues and cells. This would enable cellular characteristics to be recognized and differentiated in more detail.

bottom of page